APA (7th ed.) Citation

R, H., A, T., JJ, N., MR, P., J, B., FL, C., . . . JL, G. (2019). Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial. JAMA oncology, 5(3), 351. https://doi.org/10.1001/jamaoncol.2018.5428

Chicago Style (17th ed.) Citation

R, Hassan, et al. "Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial." JAMA Oncology 5, no. 3 (2019): 351. https://doi.org/10.1001/jamaoncol.2018.5428.

MLA (9th ed.) Citation

R, Hassan, et al. "Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial." JAMA Oncology, vol. 5, no. 3, 2019, p. 351, https://doi.org/10.1001/jamaoncol.2018.5428.